 | • レポートコード：MRC2-11QY06845 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はグルカゴン様ペプチド2受容体のグローバル市場について調査・分析したレポートです。種類別（FE-203799、グレパグルチド、GXG-8、HM-15910、その他）市場規模、用途別（短腸症候群、糖尿病、下痢、肥満、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グルカゴン様ペプチド2受容体の競争状況、市場シェア ・世界のグルカゴン様ペプチド2受容体市場：種類別市場規模 2015年-2020年（FE-203799、グレパグルチド、GXG-8、HM-15910、その他） ・世界のグルカゴン様ペプチド2受容体市場：種類別市場規模予測 2021年-2026年（FE-203799、グレパグルチド、GXG-8、HM-15910、その他） ・世界のグルカゴン様ペプチド2受容体市場：用途別市場規模 2015年-2020年（短腸症候群、糖尿病、下痢、肥満、その他） ・世界のグルカゴン様ペプチド2受容体市場：用途別市場規模予測 2021年-2026年（短腸症候群、糖尿病、下痢、肥満、その他） ・北米のグルカゴン様ペプチド2受容体市場分析：米国、カナダ ・ヨーロッパのグルカゴン様ペプチド2受容体市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグルカゴン様ペプチド2受容体市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグルカゴン様ペプチド2受容体市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグルカゴン様ペプチド2受容体市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Hanmi Pharmaceuticals Co Ltd、Naia Ltd、Takeda、Tasly Pharmaceutical Group Co Ltd、Zealand Pharma AS ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Glucagon Like Peptide 2 Receptor Market
The global Glucagon Like Peptide 2 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glucagon Like Peptide 2 Receptor Scope and Market Size
Glucagon Like Peptide 2 Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucagon Like Peptide 2 Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glucagon Like Peptide 2 Receptor market is segmented into
FE-203799
Glepaglutide
GXG-8
HM-15910
Others
Segment by Application, the Glucagon Like Peptide 2 Receptor market is segmented into
Short Bowel Syndrome
Diabetes
Diarrhea
Obesity
Others
Regional and Country-level Analysis
The Glucagon Like Peptide 2 Receptor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glucagon Like Peptide 2 Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glucagon Like Peptide 2 Receptor Market Share Analysis
Glucagon Like Peptide 2 Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glucagon Like Peptide 2 Receptor business, the date to enter into the Glucagon Like Peptide 2 Receptor market, Glucagon Like Peptide 2 Receptor product introduction, recent developments, etc.
The major vendors covered:
Hanmi Pharmaceuticals Co Ltd
Naia Ltd
Takeda
Tasly Pharmaceutical Group Co Ltd
Zealand Pharma AS
…
1 Study Coverage
1.1 Glucagon Like Peptide 2 Receptor Product Introduction
1.2 Market Segments
1.3 Key Glucagon Like Peptide 2 Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type
1.4.2 FE-203799
1.4.3 Glepaglutide
1.4.4 GXG-8
1.4.5 HM-15910
1.4.6 Others
1.5 Market by Application
1.5.1 Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application
1.5.2 Short Bowel Syndrome
1.5.3 Diabetes
1.5.4 Diarrhea
1.5.5 Obesity
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glucagon Like Peptide 2 Receptor Market Size, Estimates and Forecasts
2.1.1 Global Glucagon Like Peptide 2 Receptor Revenue 2015-2026
2.1.2 Global Glucagon Like Peptide 2 Receptor Sales 2015-2026
2.2 Global Glucagon Like Peptide 2 Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glucagon Like Peptide 2 Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glucagon Like Peptide 2 Receptor Competitor Landscape by Players
3.1 Glucagon Like Peptide 2 Receptor Sales by Manufacturers
3.1.1 Glucagon Like Peptide 2 Receptor Sales by Manufacturers (2015-2020)
3.1.2 Glucagon Like Peptide 2 Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Glucagon Like Peptide 2 Receptor Revenue by Manufacturers
3.2.1 Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glucagon Like Peptide 2 Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glucagon Like Peptide 2 Receptor Revenue in 2019
3.2.5 Global Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glucagon Like Peptide 2 Receptor Price by Manufacturers
3.4 Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution, Product Types
3.4.1 Glucagon Like Peptide 2 Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glucagon Like Peptide 2 Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glucagon Like Peptide 2 Receptor Market Size by Type (2015-2020)
4.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020)
4.1.2 Global Glucagon Like Peptide 2 Receptor Revenue by Type (2015-2020)
4.1.3 Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glucagon Like Peptide 2 Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glucagon Like Peptide 2 Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glucagon Like Peptide 2 Receptor Market Size by Application (2015-2020)
5.1.1 Global Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020)
5.1.2 Global Glucagon Like Peptide 2 Receptor Revenue by Application (2015-2020)
5.1.3 Glucagon Like Peptide 2 Receptor Price by Application (2015-2020)
5.2 Glucagon Like Peptide 2 Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Glucagon Like Peptide 2 Receptor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glucagon Like Peptide 2 Receptor by Country
6.1.1 North America Glucagon Like Peptide 2 Receptor Sales by Country
6.1.2 North America Glucagon Like Peptide 2 Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Type
6.3 North America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Application
7 Europe
7.1 Europe Glucagon Like Peptide 2 Receptor by Country
7.1.1 Europe Glucagon Like Peptide 2 Receptor Sales by Country
7.1.2 Europe Glucagon Like Peptide 2 Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Type
7.3 Europe Glucagon Like Peptide 2 Receptor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glucagon Like Peptide 2 Receptor by Region
8.1.1 Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region
8.1.2 Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Type
8.3 Asia Pacific Glucagon Like Peptide 2 Receptor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glucagon Like Peptide 2 Receptor by Country
9.1.1 Latin America Glucagon Like Peptide 2 Receptor Sales by Country
9.1.2 Latin America Glucagon Like Peptide 2 Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Type
9.3 Central & South America Glucagon Like Peptide 2 Receptor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glucagon Like Peptide 2 Receptor by Country
10.1.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country
10.1.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Facts & Figures by Application
11 Company Profiles
11.1 Hanmi Pharmaceuticals Co Ltd
11.1.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
11.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
11.1.3 Hanmi Pharmaceuticals Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
11.1.5 Hanmi Pharmaceuticals Co Ltd Related Developments
11.2 Naia Ltd
11.2.1 Naia Ltd Corporation Information
11.2.2 Naia Ltd Description and Business Overview
11.2.3 Naia Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Products Offered
11.2.5 Naia Ltd Related Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Description and Business Overview
11.3.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Takeda Glucagon Like Peptide 2 Receptor Products Offered
11.3.5 Takeda Related Developments
11.4 Tasly Pharmaceutical Group Co Ltd
11.4.1 Tasly Pharmaceutical Group Co Ltd Corporation Information
11.4.2 Tasly Pharmaceutical Group Co Ltd Description and Business Overview
11.4.3 Tasly Pharmaceutical Group Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
11.4.5 Tasly Pharmaceutical Group Co Ltd Related Developments
11.5 Zealand Pharma AS
11.5.1 Zealand Pharma AS Corporation Information
11.5.2 Zealand Pharma AS Description and Business Overview
11.5.3 Zealand Pharma AS Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Products Offered
11.5.5 Zealand Pharma AS Related Developments
11.1 Hanmi Pharmaceuticals Co Ltd
11.1.1 Hanmi Pharmaceuticals Co Ltd Corporation Information
11.1.2 Hanmi Pharmaceuticals Co Ltd Description and Business Overview
11.1.3 Hanmi Pharmaceuticals Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
11.1.5 Hanmi Pharmaceuticals Co Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glucagon Like Peptide 2 Receptor Market Estimates and Projections by Region
12.1.1 Global Glucagon Like Peptide 2 Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Glucagon Like Peptide 2 Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Glucagon Like Peptide 2 Receptor Sales Forecast (2021-2026)
12.2.2 North America: Glucagon Like Peptide 2 Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Glucagon Like Peptide 2 Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Glucagon Like Peptide 2 Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Glucagon Like Peptide 2 Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glucagon Like Peptide 2 Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glucagon Like Peptide 2 Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glucagon Like Peptide 2 Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glucagon Like Peptide 2 Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Glucagon Like Peptide 2 Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Glucagon Like Peptide 2 Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Glucagon Like Peptide 2 Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glucagon Like Peptide 2 Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glucagon Like Peptide 2 Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glucagon Like Peptide 2 Receptor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glucagon Like Peptide 2 Receptor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glucagon Like Peptide 2 Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glucagon Like Peptide 2 Receptor Market Segments
Table 2. Ranking of Global Top Glucagon Like Peptide 2 Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of FE-203799
Table 5. Major Manufacturers of Glepaglutide
Table 6. Major Manufacturers of GXG-8
Table 7. Major Manufacturers of HM-15910
Table 8. Major Manufacturers of Others
Table 9. Global Glucagon Like Peptide 2 Receptor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Glucagon Like Peptide 2 Receptor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Glucagon Like Peptide 2 Receptor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Regions (2015-2020)
Table 13. Global Glucagon Like Peptide 2 Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Glucagon Like Peptide 2 Receptor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Glucagon Like Peptide 2 Receptor Sales Share by Manufacturers (2015-2020)
Table 16. Global Glucagon Like Peptide 2 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Glucagon Like Peptide 2 Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2019)
Table 18. Glucagon Like Peptide 2 Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Glucagon Like Peptide 2 Receptor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Glucagon Like Peptide 2 Receptor Price (2015-2020) (USD/Pcs)
Table 21. Glucagon Like Peptide 2 Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Glucagon Like Peptide 2 Receptor Product Type
Table 23. Date of International Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Glucagon Like Peptide 2 Receptor Sales Share by Type (2015-2020)
Table 27. Global Glucagon Like Peptide 2 Receptor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Glucagon Like Peptide 2 Receptor Revenue Share by Type (2015-2020)
Table 29. Glucagon Like Peptide 2 Receptor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Glucagon Like Peptide 2 Receptor Sales Share by Application (2015-2020)
Table 32. North America Glucagon Like Peptide 2 Receptor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2015-2020)
Table 34. North America Glucagon Like Peptide 2 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2015-2020)
Table 36. North America Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Table 38. North America Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Table 40. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2015-2020)
Table 42. Europe Glucagon Like Peptide 2 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2015-2020)
Table 44. Europe Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Table 46. Europe Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Table 56. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Glucagon Like Peptide 2 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Table 62. Latin America Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Table 72. Hanmi Pharmaceuticals Co Ltd Corporation Information
Table 73. Hanmi Pharmaceuticals Co Ltd Description and Major Businesses
Table 74. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Hanmi Pharmaceuticals Co Ltd Product
Table 76. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 77. Naia Ltd Corporation Information
Table 78. Naia Ltd Description and Major Businesses
Table 79. Naia Ltd Glucagon Like Peptide 2 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Naia Ltd Product
Table 81. Naia Ltd Recent Development
Table 82. Takeda Corporation Information
Table 83. Takeda Description and Major Businesses
Table 84. Takeda Glucagon Like Peptide 2 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Takeda Product
Table 86. Takeda Recent Development
Table 87. Tasly Pharmaceutical Group Co Ltd Corporation Information
Table 88. Tasly Pharmaceutical Group Co Ltd Description and Major Businesses
Table 89. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Tasly Pharmaceutical Group Co Ltd Product
Table 91. Tasly Pharmaceutical Group Co Ltd Recent Development
Table 92. Zealand Pharma AS Corporation Information
Table 93. Zealand Pharma AS Description and Major Businesses
Table 94. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Zealand Pharma AS Product
Table 96. Zealand Pharma AS Recent Development
Table 97. Global Glucagon Like Peptide 2 Receptor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Glucagon Like Peptide 2 Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Glucagon Like Peptide 2 Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Glucagon Like Peptide 2 Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Glucagon Like Peptide 2 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Glucagon Like Peptide 2 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Glucagon Like Peptide 2 Receptor Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Glucagon Like Peptide 2 Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Glucagon Like Peptide 2 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Glucagon Like Peptide 2 Receptor Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Glucagon Like Peptide 2 Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Glucagon Like Peptide 2 Receptor Players
Table 115. Glucagon Like Peptide 2 Receptor Customers List
Table 116. Glucagon Like Peptide 2 Receptor Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide 2 Receptor Product Picture
Figure 2. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. FE-203799 Product Picture
Figure 4. Glepaglutide Product Picture
Figure 5. GXG-8 Product Picture
Figure 6. HM-15910 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2020 & 2026
Figure 9. Short Bowel Syndrome
Figure 10. Diabetes
Figure 11. Diarrhea
Figure 12. Obesity
Figure 13. Others
Figure 14. Glucagon Like Peptide 2 Receptor Report Years Considered
Figure 15. Global Glucagon Like Peptide 2 Receptor Market Size 2015-2026 (US$ Million)
Figure 16. Global Glucagon Like Peptide 2 Receptor Sales 2015-2026 (K Pcs)
Figure 17. Global Glucagon Like Peptide 2 Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region (2015-2020)
Figure 19. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2019
Figure 20. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region (2015-2020)
Figure 21. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2019
Figure 22. Global Glucagon Like Peptide 2 Receptor Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Glucagon Like Peptide 2 Receptor Revenue in 2019
Figure 24. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type (2015-2020)
Figure 26. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2019
Figure 27. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type (2015-2020)
Figure 28. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Type in 2019
Figure 29. Global Glucagon Like Peptide 2 Receptor Market Share by Price Range (2015-2020)
Figure 30. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application (2015-2020)
Figure 31. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2019
Figure 32. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application (2015-2020)
Figure 33. Global Glucagon Like Peptide 2 Receptor Revenue Market Share by Application in 2019
Figure 34. North America Glucagon Like Peptide 2 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2019
Figure 37. North America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2019
Figure 38. U.S. Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Glucagon Like Peptide 2 Receptor Market Share by Type in 2019
Figure 43. North America Glucagon Like Peptide 2 Receptor Market Share by Application in 2019
Figure 44. Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2019
Figure 47. Europe Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2019
Figure 48. Germany Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Glucagon Like Peptide 2 Receptor Market Share by Type in 2019
Figure 59. Europe Glucagon Like Peptide 2 Receptor Market Share by Application in 2019
Figure 60. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Market Share by Region in 2019
Figure 63. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Market Share by Region in 2019
Figure 64. China Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Glucagon Like Peptide 2 Receptor Market Share by Type in 2019
Figure 87. Asia Pacific Glucagon Like Peptide 2 Receptor Market Share by Application in 2019
Figure 88. Latin America Glucagon Like Peptide 2 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2019
Figure 91. Latin America Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2019
Figure 92. Mexico Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Glucagon Like Peptide 2 Receptor Market Share by Type in 2019
Figure 99. Latin America Glucagon Like Peptide 2 Receptor Market Share by Application in 2019
Figure 100. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Market Share by Country in 2019
Figure 104. Turkey Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Glucagon Like Peptide 2 Receptor Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Glucagon Like Peptide 2 Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Share by Type in 2019
Figure 111. Middle East and Africa Glucagon Like Peptide 2 Receptor Market Share by Application in 2019
Figure 112. North America Glucagon Like Peptide 2 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Glucagon Like Peptide 2 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Glucagon Like Peptide 2 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Glucagon Like Peptide 2 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Glucagon Like Peptide 2 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Glucagon Like Peptide 2 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Glucagon Like Peptide 2 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Glucagon Like Peptide 2 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Glucagon Like Peptide 2 Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
N-ホルミルペプチド受容体2の世界市場（～2026年） Market Analysis and Insights: Global N-Formyl Peptide Receptor 2 Market The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global N-Formyl Peptide Receptor 2 Scope and Market Size N-Formyl …- カルシトニン遺伝子関連ペプチド1型受容体の世界市場（～2026年） Market Analysis and Insights: Global Calcitonin Gene Related Peptide Type 1 Receptor Market The global Calcitonin Gene Related Peptide Type 1 Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcitonin Gene Rel…
- ペプチド胃腸障害治療薬の世界市場（～2026年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- ペプチド感染症治療薬の世界市場（～2026年） Peptide therapeutics are stable, safe, tolerable, possess selective nature, and effective. Hospital pharmacies segment enjoys the highest market share by revenue thereby dominating the global market. Market Analysis and Insights: Global Peptide Based Infection Therapeutics Market The global Peptide …
- ペプチド癌治療薬の世界市場（～2026年） Peptide is a compound that is created by artificial or natural biological chaining of amino acid monomers. In recent years, peptides have emerged as an effective therapeutic agent in treatment of various diseases, including cancer. Market Analysis and Insights: Global Peptide Based Cancer Therapeuti…